AGGIORNAMENTO SCIENTIFICO IN TEMPO REALE FORNITO DA:

Top News

  • Better Educational Achievement in Kids Who Delay Gratification
    by Neuroscience News on 20 Aprile 2024

    Researchers adapted the "delay of gratification" test for Singaporean preschool children, offering insights into self-regulation development in Asian contexts. The research involved children choosing between smaller immediate rewards and larger delayed rewards, revealing key developmental and socioeconomic factors influencing their choices.

  • Why We Forget: New Insights into Everyday Memory
    by Neuroscience News on 20 Aprile 2024

    A new study investigates why everyday actions like locking a door are often forgotten. Researchers explored how people tend to remember significant events rather than routine details.

  • New Insights into Protein Accumulation in Alzheimer’s
    by Neuroscience News on 20 Aprile 2024

    Researchers made a significant discovery in understanding the mechanisms behind protein accumulation in neurodegenerative diseases like Alzheimer’s. By studying fruit flies, the team found that a reduction in mitochondria within neuron axons leads directly to this detrimental protein buildup.

  • Risks of Antipsychotic Use in Dementia Patients
    by Neuroscience News on 20 Aprile 2024

    A new study revealed significant risks associated with antipsychotic use in dementia patients, including increased chances of stroke, heart failure, pneumonia, and other serious conditions. The research analyzed data from 173,910 dementia patients in England, tracking those prescribed antipsychotics post-diagnosis against those who were not.

  • Blessed Thistle Enhances Nerve Regeneration
    by Neuroscience News on 19 Aprile 2024

    Cnicin, a compound derived from the plant Blessed Thistle, significantly enhances nerve regeneration. The study shows that Cnicin can accelerate the growth of axons, the long fibers of nerve cells, which is crucial for the recovery of nerve function after injury.

  • CAR-T Trial Targets Glioblastoma Brain Cancer
    by Neuroscience News on 19 Aprile 2024

    Researchers initiated a pioneering clinical trial using an advanced form of CAR-T therapy, enhanced by synthetic notch (synNotch) technology, to treat glioblastoma. This trial represents a significant shift towards targeted, safer cancer therapies.

  • Eye Tests Predict Parkinson’s Progression
    by Neuroscience News on 19 Aprile 2024

    Optical coherence tomography, commonly used in eye exams, can monitor neurodegeneration in Parkinson's disease patients by measuring the thickness of the retina. This method has revealed that retinal degeneration often precedes cognitive and motor decline, offering a potential early indicator of disease progression.

  • Novel DNA Mechanism in Memory Discovered
    by Neuroscience News on 19 Aprile 2024

    Researchers identified a novel mechanism that impacts memory formation through changes in DNA structure, specifically G-quadruplex DNA (G4-DNA). Their study reveals that G4-DNA accumulates in neurons, dynamically influencing gene activation and repression crucial for long-term memory.

  • Blood Test Predicts Multiple Sclerosis Years Before Symptoms Appear
    by Neuroscience News on 19 Aprile 2024

    Researchers identified a specific pattern of autoantibodies in the blood that precedes the clinical onset of multiple sclerosis (MS), potentially paving the way for early diagnosis and treatment. Their study found that 10% of MS patients displayed a unique set of autoantibodies against both human proteins and common pathogens like the Epstein-Barr Virus years before showing symptoms.

  • CBD’s Neuroprotective Properties Explored
    by Neuroscience News on 18 Aprile 2024

    Summary: Cannabinol (CBN), a cannabinoid derived from cannabis, offers neuroprotective properties that could treat neurological disorders like Alzheimer’s, Parkinson’s, and traumatic brain injuries. Their study details how CBN and its newly developed analogs prevent mitochondrial dysfunction in neurons, a common factor in these diseases. The team synthesized four CBN-based compounds, finding one, in particular, to be highly effective in a fruit fly model of brain injury. These findings not only highlight CBN’s therapeutic potential but also pave the way for

  • Treatment Relieves Chronic Lyme Disease’s Neurological Symptoms
    by Neuroscience News on 18 Aprile 2024

    Fibroblast growth factor receptor inhibitors, commonly used in cancer treatment, could effectively reduce neurological symptoms in patients with post-treatment Lyme disease syndrome. The study shows these inhibitors can decrease inflammation and cell death in brain and nerve tissues affected by Lyme disease.

  • How Drugs Hijack the Brain’s Reward System
    by Neuroscience News on 18 Aprile 2024

    Researchers made significant advances in understanding how drugs like cocaine and morphine disrupt the brain's natural reward mechanisms. Their study reveals that these drugs manipulate the same brain cells responsible for processing natural rewards, leading to compulsive drug-seeking behaviors.